About Fertility Services
Couples with fertility issues are unable to conceive even after regular unprotected coitus. Infertility complications are widespread, with either female or male infertility factors accounting for one-third of the cases. In the rest of the cases, the cause is either unknown or a combination of both male and female infertility factors. Low sperm production, abnormal sperm function, or blockages that prevent the delivery of sperm are some of the factors that can lead to infertility in males. Hormonal changes, fallopian tube damage, endometriosis, and cervical abnormalities are factors that can lead to infertility in women. Diagnosing the cause of infertility can be difficult, but people with fertility issues can choose from a variety of treatment options, depending on the underlying problem.
Technavio’s analysts forecast the global fertility services market to grow at a CAGR of 8.72% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global fertility services market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales and use of infertility drugs and assisted reproductive technology (ART).
The market is divided into the following segments based on geography:
Press Release
Technavio Announces the Publication of its Research Report – Global Fertility Services Market 2016-2020
Technavio recognizes the following companies as the key players in the Global Fertility Services Market: Carefertility, Coopersurgical, Ferring Pharmaceuticals, Merck, MonashIVF, and Vitrolife.
Other Prominent Vendors in the market are: Abbott Laboratories, AbbVie, Actavis, Apricus Biosciences, AstraZeneca, Auxogyn, Bristol-Myers Squibb, Cell Cura, Dong-A Socio, Elelixis Diagnostics, Eli Lilly, EMD Serono, Fertility Focus, Halotech, HRA Pharma, IKS International, In Vitro Care, Invo Bioscience, Irvine Scientific, IVFtech Aps, Kitazato, Life Global, Medical Electronic Systems, Meditex, Microtech IVF, Nidacon International, Novartis, NuSep, Ovascience, Pantec Biosolutions, Pfizer, PregLem, Reproductive Health Science, ReproTech, Sanofi, Smiths Medical International, Sperm Processor, Vitrolife, Vivus, and Xytex Cryo International.
Commenting on the report, an analyst from Technavio’s team said: “The rising demand for fertility services will require an increase in the volume of supply. Governments of various countries are establishing new fertility clinics to manage the demand for fertility services. Vendors are conducting R&D to further improve the technology of available fertility services and develop innovative techniques.”
According to the report, with aging, the human body undergoes various physiological and hormonal changes that can contribute to problems related to fertility. Medical studies by different research institutes state that women aged 35 years and above face various complications related to fertility. These studies estimate that women in this age group have an infertility rate of over 35%. Aging causes decreased sperm motility in men. The presence of obesity adds to fertility complications in both men and women. Obesity is a known cause of infertility, as it leads to problems with ovulation and low sperm count.
Further, the report states that the cost of fertility services is high in the US compared to countries such as India, Taiwan, and Hong Kong. Fertility services can lead to multiple pregnancies, internal bleeding or infection, and congenital defects. Costs related to the treatment of these complications can further increase the overall costs for people undergoing fertility services.
Companies Mentioned
Carefertility, Coopersurgical, Ferring Pharmaceuticals, Merck, MonashIVF, Vitrolife, Abbott Laboratories, AbbVie, Actavis, Apricus Biosciences, AstraZeneca, Auxogyn, Bristol-Myers Squibb, Cell Cura, Dong-A Socio, Elelixis Diagnostics, Eli Lilly, EMD Serono, Fertility Focus, Halotech, HRA Pharma, IKS International, In Vitro Care, Invo Bioscience, Irvine Scientific, IVFtech Aps, Kitazato, Life Global, Medical Electronic Systems, Meditex, Microtech IVF, Nidacon International, Novartis, NuSep, Ovascience, Pantec Biosolutions, Pfizer, PregLem, Reproductive Health Science, ReproTech, Sanofi, Smiths Medical International, Sperm Processor, Vitrolife, Vivus, Xytex Cryo International.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook